Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-alpha antibody infliximab.
Yazdani-Biuki
B
B
Stelzl
H
H
Brezinschek
H P
HP
Hermann
J
J
Mueller
T
T
Krippl
P
P
Graninger
W
W
Wascher
T C
TC
D000328:Adult; D000368:Aged; D000906:Antibodies / Q000276:immunology*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D007328:Insulin / Q000502:physiology*; D007333:Insulin Resistance / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000906:Antibodies; D000911:Antibodies, Monoclonal; D007328:Insulin; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab